Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bifidobacterium longum protein, and preparation method and medical application thereof

A bifidobacterium longum and protein technology, applied in the field of microorganisms, can solve problems such as singleness and lack of ingredients, and achieve the effects of expanding the scope of use, improving sensitivity, and improving microbial drug sensitivity

Active Publication Date: 2016-06-15
NANCHANG UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention aims at the technical defects of the prior art, and provides a Bifidobacterium longum protein, its preparation method and medical application, so as to solve the problem of the lack of a bifidobacterium adhesion protein with a single component and a clear structure in the prior art. technical problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bifidobacterium longum protein, and preparation method and medical application thereof
  • Bifidobacterium longum protein, and preparation method and medical application thereof
  • Bifidobacterium longum protein, and preparation method and medical application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1 (recombinant escherichia coli expression strain that prepares Bifidobacterium longum protein)

[0043] 1.1 Experimental materials

[0044] 1.1.1 Strains and vectors

[0045] Bifidobacterium longum, Escherichia coli DH5α, and vector pGEX-4T-1 were all purchased from the market.

[0046] 1.1.2 Commonly used reagents

[0047] (1) TE buffer (pH8.0): 10mmol / LTris-HCl (pH8.0), 1mmol / LEDTANa 2 (pH8.0). After configuration, autoclave and store at room temperature.

[0048] (2) 10mg / mL lysozyme: 100mg lysozyme dissolved in 10mLddH 2 O, stored at –20°C for later use.

[0049] (3) 10% SDS: 5gSDS plus ddH 2 O was dissolved and the volume was adjusted to 50 mL.

[0050] (4) 3MKAc: 14.72gKAc dissolved in ddH 2 O and make up to 50mL.

[0051] (5) 3MNaAc: 12.35gNaAc dissolved in ddH 2 O and make up to 50mL.

[0052] (6) 0.1MCaCl 2 : 11.1gCaCl 2 Dissolve in 1000mLddH 2 In O, autoclave at 121°C for 15 minutes, and store at 4°C.

[0053] (7) 50×TAE electrophor...

Embodiment 2

[0160] Example 2 (Induced expression and purification of Bifidobacterium longum adhesion protein)

[0161] Step 1: Induced expression of Bifidobacterium longum adhesion protein

[0162] The Bifidobacterium longum adhesion protein expression strain E.coliDH5αpGEX-4T-AIP2 prepared in Example 1 was induced and expressed with IPTG, and the specific steps were as follows:

[0163] (1) Pick a single colony of the strain that has been streaked on the plate, inoculate it into 3ml of LB liquid medium, add Amp to the test tube to a final concentration of 100μg / ml, and culture it at 37°C with a constant temperature shaker at 180r / m for 8h.

[0164] (2) Transfer to 20ml low-salt LB liquid medium according to 1% inoculum size, add Amp to a final concentration of 100μg / ml, and culture at 37°C with a constant temperature shaker at 180r / m.

[0165] (3) When the cell density OD600nm = 0.6-0.9, add the inducer IPTG to a final concentration of 1 mM, incubate at 37° C. with a constant temperatur...

Embodiment 3

[0186] Embodiment 3 (a kind of aminoacid sequence is the protein preparation method of SEQIDNO:1)

[0187] 1) Take recombinant Escherichia coli E.coli DH5αpGEX-4T-AIP2 and culture it. When the OD600nm of the culture medium is 0.9, add the inducer IPTG to a final concentration of 1.2mM, and then induce culture at 39°C for 5 hours under shaking conditions;

[0188] 2) collecting the bacteria, crushing, and collecting the supernatant;

[0189] 3) Take buffer A, equilibrate the glutathione agarose resin column with a flow rate of 3.5mL / min; take the supernatant from step 2), load the sample with a flow rate of 2mL / min; take buffer B, The flow rate of min is eluted, and the solution at the elution peak is collected as the eluent; the eluent is collected by ultrafiltration and concentrated, then passed through a desalting column, and then eluted with pure water at a flow rate of 3.5mL / min, and the eluent at the elution peak is collected. The solution is the second eluent, and then ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an attachment protein derived from bifidobacterium longum, and discloses the amino acid sequence thereof; on the basis, experiments discover that the attachment protein not only can attach to enterocyte, but also has the function of improving microorganism antibiotic sensitivity, and especially for escherichia coli O157:H7, the antibiotic synergy is particularly prominent. Based on the beneficial discovery, the application of the protein as an anti-bacteria synergist, escherichia coli O157:H7, is determined, so that the application range of the protein is expanded, and at the same time, a new approach is provided for improving microorganism drug sensitivity. The prominent technological effect is achieved on the basis of strict experimental measures, and a broad application prospect is obtained.

Description

technical field [0001] The invention relates to the technical field of microorganisms, in particular to a bifidobacterium longum protein, a preparation method and a medical application thereof. Background technique [0002] Bifidobacteria are widely known as intestinal probiotics. In recent years, studies on their intestinal probiotics have found that certain metabolites of Bifidobacteria can inhibit the colonization of other microorganisms on the intestinal wall, thereby reducing the risk of pathogenic microorganisms. This feature has become an important basis for screening Bifidobacterium strains and developing functional probiotic agents. [0003] Studies in the prior art have found that the inhibitory mechanism of bifidobacteria on the colonization of other microorganisms on the inner wall of the intestinal tract is mainly through the secretion of organic acids to lower the pH value of the intestinal tract, regulate the intestinal micro-ecological environment, and at the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/195C07K1/34C07K1/22C12N15/70A61K38/16A61P31/04
CPCA61K38/00C07K14/195
Inventor 徐锋杨栋魏华武晓丽蔚晓敏吴姚平
Owner NANCHANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com